BASF agrees to sell Kankakee, Illinois plant to One Rock Capital Partners
BASF has entered into an agreement to sell its Kankakee, Illinois manufacturing site and its related operations of vegetable oil-based raw materials sterols and natural vitamin E, anionic surfactants and esters to a private equity firm that is an affiliate of One Rock Capital Partners, LLC in the United States.
These businesses have approximately 160 employees in the U.S., including business management and commercial staff
The transaction is expected to close in the first half of 2021, subject to the approval of the relevant competition authorities. Terms of the transaction were not disclosed.
BASF acquired the site and its business from Cognis in 2010.
It is operated by BASF's Nutrition & Health & Care Chemicals division. Based on a recent careful market assessment, it was determined that the site is no longer a strategic site for BASF.
You May Interested In
2026-10-10
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
BASF and Henkel Partner To Replace Fossil Raw Materials With Renewable Materials For Henkel's Consumer Products
-
BASF leading in water management, forest and climate protection according to CDP
-
BASF to cut 2,000 jobs in global business services division
-
BASF pushes new raw material for stabilizers, which are natural and biodegradabl
-
Argentina to Build Latin America’s Largest Urea Plant Under €1.3 Billion Contract
-
Dow Swings from an $801 Million Loss to an $802 Million Profit as Hormuz Disruption Lifts Polyethylene Prices
-
Türkiye Advances $3 Billion Petrochemical Cluster Targeting 17% of Domestic Polypropylene Demand
-
Nouryon's Production Facilities in China Have Obtained Halal Certification for Personal Care Ingredients
-
China Activates Blocking Rules in Response to U.S. Sanctions on Petrochemical Firms
-
BASF Brings Biomass-Balance Polyols to North America
Recommend Reading
-
![Sun Pharma’s Organon Bid Would Redraw Indian Pharma M&A]()
Sun Pharma’s Organon Bid Would Redraw Indian Pharma M&A
-
![BASF Raises API and Excipient Prices]()
BASF Raises API and Excipient Prices
-
![Iran Conflict Leaves a Long Shadow on Drug Supply]()
Iran Conflict Leaves a Long Shadow on Drug Supply
-
![AstraZeneca India Eyes ₹3,400 Crore Bengaluru Sale]()
AstraZeneca India Eyes ₹3,400 Crore Bengaluru Sale
-
![Wanhua Chemical Announces 2026 Investment Plan: RMB 27.3 Billion for Projects Plus RMB 2.22 Billion for Equity Investments]()
Wanhua Chemical Announces 2026 Investment Plan: RMB 27.3 Billion for Projects Plus RMB 2.22 Billion for Equity Investments
-
![Cost Support Drives Slight Rise in Toluene Market in January]()
Cost Support Drives Slight Rise in Toluene Market in January
-
![Cost Values Make a Strong Comeback; PC Market Soars in the Second Half of July]()
Cost Values Make a Strong Comeback; PC Market Soars in the Second Half of July
-
![Support Effective, January Normal Butanol Market Price Increase Exceeds 18% in China]()
Support Effective, January Normal Butanol Market Price Increase Exceeds 18% in China
-
![Supply and Demand Both Weak, Butadiene Market Declines]()
Supply and Demand Both Weak, Butadiene Market Declines
-
![This week, the Aniline market in China continues to rise (7.20-7.24)]()
This week, the Aniline market in China continues to rise (7.20-7.24)
